Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 76 entries
Sorted by: Best Match Show Resources per page
JAG: A Computational Tool to Evaluate the Role of Gene-Sets in Complex Traits.

Genes

Lips ES, Kooyman M, de Leeuw C, Posthuma D.
PMID: 26110313
Genes (Basel). 2015 May 14;6(2):238-51. doi: 10.3390/genes6020238.

Gene-set analysis has been proposed as a powerful tool to deal with the highly polygenic architecture of complex traits, as well as with the small effect sizes typically found in GWAS studies for complex traits. We developed a tool,...

Cite
Lips ES, Kooyman M, de Leeuw C, et al. JAG: A Computational Tool to Evaluate the Role of Gene-Sets in Complex Traits. Genes (Basel). 2015;6(2):238-51doi: 10.3390/genes6020238.
Lips, E. S., Kooyman, M., de Leeuw, C., & Posthuma, D. (2015). JAG: A Computational Tool to Evaluate the Role of Gene-Sets in Complex Traits. Genes, 6(2), 238-51. https://doi.org/10.3390/genes6020238
Lips, Esther S, et al. "JAG: A Computational Tool to Evaluate the Role of Gene-Sets in Complex Traits." Genes vol. 6,2 (2015): 238-51. doi: https://doi.org/10.3390/genes6020238
Lips ES, Kooyman M, de Leeuw C, Posthuma D. JAG: A Computational Tool to Evaluate the Role of Gene-Sets in Complex Traits. Genes (Basel). 2015 May 14;6(2):238-51. doi: 10.3390/genes6020238. PMID: 26110313; PMCID: PMC4488663.
Copy Download .nbib Format: NLM
Impact of CFTR Modulation on Intestinal pH, Motility, and Clinical Outcomes in Patients With Cystic Fibrosis and the G551D Mutation.

Clinical and translational gastroenterology

Gelfond D, Heltshe S, Ma C, Rowe SM, Frederick C, Uluer A, Sicilian L, Konstan M, Tullis E, Roach RN, Griffin K, Joseloff E, Borowitz D.
PMID: 28300821
Clin Transl Gastroenterol. 2017 Mar 16;8(3):e81. doi: 10.1038/ctg.2017.10.

OBJECTIVES: A defect in bicarbonate secretion contributes to the pathophysiology of gastrointestinal complications in patients with cystic fibrosis (CF). We measured gastrointestinal pH, clinical outcomes, and intestinal transit profiles in patients with the G551D mutation before and after treatment...

Cite
Gelfond D, Heltshe S, Ma C, et al. Impact of CFTR Modulation on Intestinal pH, Motility, and Clinical Outcomes in Patients With Cystic Fibrosis and the G551D Mutation. Clin Transl Gastroenterol. 2017;8(3):e81doi: 10.1038/ctg.2017.10.
Gelfond, D., Heltshe, S., Ma, C., Rowe, S. M., Frederick, C., Uluer, A., Sicilian, L., Konstan, M., Tullis, E., Roach, R. N., Griffin, K., Joseloff, E., & Borowitz, D. (2017). Impact of CFTR Modulation on Intestinal pH, Motility, and Clinical Outcomes in Patients With Cystic Fibrosis and the G551D Mutation. Clinical and translational gastroenterology, 8(3), e81. https://doi.org/10.1038/ctg.2017.10
Gelfond, Daniel, et al. "Impact of CFTR Modulation on Intestinal pH, Motility, and Clinical Outcomes in Patients With Cystic Fibrosis and the G551D Mutation." Clinical and translational gastroenterology vol. 8,3 (2017): e81. doi: https://doi.org/10.1038/ctg.2017.10
Gelfond D, Heltshe S, Ma C, Rowe SM, Frederick C, Uluer A, Sicilian L, Konstan M, Tullis E, Roach RN, Griffin K, Joseloff E, Borowitz D. Impact of CFTR Modulation on Intestinal pH, Motility, and Clinical Outcomes in Patients With Cystic Fibrosis and the G551D Mutation. Clin Transl Gastroenterol. 2017 Mar 16;8(3):e81. doi: 10.1038/ctg.2017.10. PMID: 28300821; PMCID: PMC5387753.
Copy Download .nbib Format: NLM
Systemic adverse events in imiquimod use for cervical intraepithelial neoplasia - A case series.

Case reports in women's health

Wouters T, Hendriks N, Koeneman M, Kruse AJ, van de Sande A, van Beekhuizen HJ, Gerestein KG, Bekkers RLM, Piek JMJ.
PMID: 30906696
Case Rep Womens Health. 2019 Mar 06;21:e00105. doi: 10.1016/j.crwh.2019.e00105. eCollection 2019 Jan.

Treatment for cervical intraepithelial neoplasia (CIN) often consists of an excisional procedure. However, less invasive treatment methods have been explored, such as topical treatment with imiquimod cream. Imiquimod has been proven to be effective in the regression of vulvar...

Cite
Wouters T, Hendriks N, Koeneman M, et al. Systemic adverse events in imiquimod use for cervical intraepithelial neoplasia - A case series. Case Rep Womens Health. 2019;21:e00105doi: 10.1016/j.crwh.2019.e00105.
Wouters, T., Hendriks, N., Koeneman, M., Kruse, A. J., van de Sande, A., van Beekhuizen, H. J., Gerestein, K. G., Bekkers, R. L. M., & Piek, J. M. J. (2019). Systemic adverse events in imiquimod use for cervical intraepithelial neoplasia - A case series. Case reports in women's health, 21e00105. https://doi.org/10.1016/j.crwh.2019.e00105
Wouters, Tirza, et al. "Systemic adverse events in imiquimod use for cervical intraepithelial neoplasia - A case series." Case reports in women's health vol. 21 (2019): e00105. doi: https://doi.org/10.1016/j.crwh.2019.e00105
Wouters T, Hendriks N, Koeneman M, Kruse AJ, van de Sande A, van Beekhuizen HJ, Gerestein KG, Bekkers RLM, Piek JMJ. Systemic adverse events in imiquimod use for cervical intraepithelial neoplasia - A case series. Case Rep Womens Health. 2019 Mar 06;21:e00105. doi: 10.1016/j.crwh.2019.e00105. eCollection 2019 Jan. PMID: 30906696; PMCID: PMC6411488.
Copy Download .nbib Format: NLM
Work Ability in Patients With Stage I-IV Colon Cancer: Results of the Dutch Prospective Colorectal Cancer Cohort.

Diseases of the colon and rectum

Franken MD, Vink GR, van Grevenstein WMU, Verkooijen HM, Punt CJA, Koopman M, May AM.
PMID: 34753892
Dis Colon Rectum. 2021 Oct 21; doi: 10.1097/DCR.0000000000002075. Epub 2021 Oct 21.

BACKGROUND: Colon cancer affects a patient's ability to work. Many colon cancer patients are employed at the time of diagnosis.OBJECTIVE: We evaluated work ability during the first two years after colon cancer diagnosis.DESIGN: This study is a national prospective...

Cite
Franken MD, Vink GR, van Grevenstein WMU, et al. Work Ability in Patients With Stage I-IV Colon Cancer: Results of the Dutch Prospective Colorectal Cancer Cohort. Dis Colon Rectum. 2021;doi: 10.1097/DCR.0000000000002075.
Franken, M. D., Vink, G. R., van Grevenstein, W. M. U., Verkooijen, H. M., Punt, C. J. A., Koopman, M., May, A. M. (2021). Work Ability in Patients With Stage I-IV Colon Cancer: Results of the Dutch Prospective Colorectal Cancer Cohort. Diseases of the colon and rectum, . https://doi.org/10.1097/DCR.0000000000002075
Franken, Mira D, et al. "Work Ability in Patients With Stage I-IV Colon Cancer: Results of the Dutch Prospective Colorectal Cancer Cohort." Diseases of the colon and rectum vol. (2021). doi: https://doi.org/10.1097/DCR.0000000000002075
Franken MD, Vink GR, van Grevenstein WMU, Verkooijen HM, Punt CJA, Koopman M, May AM. Work Ability in Patients With Stage I-IV Colon Cancer: Results of the Dutch Prospective Colorectal Cancer Cohort. Dis Colon Rectum. 2021 Oct 21; doi: 10.1097/DCR.0000000000002075. Epub 2021 Oct 21. PMID: 34753892.
Copy Download .nbib Format: NLM
A pilot study on the feasibility and effectiveness of treadmill-based perturbations for assessing and improving walking stability in chronic obstructive pulmonary disease.

Clinical biomechanics (Bristol, Avon)

McCrum C, Vaes AW, Delbressine JM, Koopman M, Liu WY, Willems P, Meijer K, Spruit MA.
PMID: 34823220
Clin Biomech (Bristol, Avon). 2021 Nov 21;91:105538. doi: 10.1016/j.clinbiomech.2021.105538. Epub 2021 Nov 21.

BACKGROUND: Falls risk is elevated in chronic obstructive pulmonary disease (COPD). However, there is a lack of evidence regarding the contributing factors. Here, we examined the feasibility of, and initial responses to, large walking perturbations in COPD, as well...

Cite
McCrum C, Vaes AW, Delbressine JM, et al. A pilot study on the feasibility and effectiveness of treadmill-based perturbations for assessing and improving walking stability in chronic obstructive pulmonary disease. Clin Biomech (Bristol, Avon). 2021;91:105538doi: 10.1016/j.clinbiomech.2021.105538.
McCrum, C., Vaes, A. W., Delbressine, J. M., Koopman, M., Liu, W. Y., Willems, P., Meijer, K., & Spruit, M. A. (2021). A pilot study on the feasibility and effectiveness of treadmill-based perturbations for assessing and improving walking stability in chronic obstructive pulmonary disease. Clinical biomechanics (Bristol, Avon), 91105538. https://doi.org/10.1016/j.clinbiomech.2021.105538
McCrum, Christopher, et al. "A pilot study on the feasibility and effectiveness of treadmill-based perturbations for assessing and improving walking stability in chronic obstructive pulmonary disease." Clinical biomechanics (Bristol, Avon) vol. 91 (2021): 105538. doi: https://doi.org/10.1016/j.clinbiomech.2021.105538
McCrum C, Vaes AW, Delbressine JM, Koopman M, Liu WY, Willems P, Meijer K, Spruit MA. A pilot study on the feasibility and effectiveness of treadmill-based perturbations for assessing and improving walking stability in chronic obstructive pulmonary disease. Clin Biomech (Bristol, Avon). 2021 Nov 21;91:105538. doi: 10.1016/j.clinbiomech.2021.105538. Epub 2021 Nov 21. PMID: 34823220.
Copy Download .nbib Format: NLM
Early Cost-effectiveness Analysis of Risk-Based Selection Strategies for Adjuvant Treatment in Stage II Colon Cancer: The Potential Value of Prognostic Molecular Markers.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Jongeneel G, Greuter MJE, Kunst N, van Erning FN, Koopman M, Medema JP, Vermeulen L, Ijzermans JNM, Vink GR, Punt CJA, Coupé VMH.
PMID: 34162659
Cancer Epidemiol Biomarkers Prev. 2021 Sep;30(9):1726-1734. doi: 10.1158/1055-9965.EPI-21-0078. Epub 2021 Jun 23.

BACKGROUND: To explore the potential value of consensus molecular subtypes (CMS) in stage II colon cancer treatment selection, we carried out an early cost-effectiveness assessment of a CMS-based strategy for adjuvant chemotherapy.METHODS: We used a Markov cohort model to...

Cite
Jongeneel G, Greuter MJE, Kunst N, et al. Early Cost-effectiveness Analysis of Risk-Based Selection Strategies for Adjuvant Treatment in Stage II Colon Cancer: The Potential Value of Prognostic Molecular Markers. Cancer Epidemiol Biomarkers Prev. 2021;30(9):1726-1734doi: 10.1158/1055-9965.EPI-21-0078.
Jongeneel, G., Greuter, M. J. E., Kunst, N., van Erning, F. N., Koopman, M., Medema, J. P., Vermeulen, L., Ijzermans, J. N. M., Vink, G. R., Punt, C. J. A., & Coupé, V. M. H. (2021). Early Cost-effectiveness Analysis of Risk-Based Selection Strategies for Adjuvant Treatment in Stage II Colon Cancer: The Potential Value of Prognostic Molecular Markers. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 30(9), 1726-1734. https://doi.org/10.1158/1055-9965.EPI-21-0078
Jongeneel, Gabrielle, et al. "Early Cost-effectiveness Analysis of Risk-Based Selection Strategies for Adjuvant Treatment in Stage II Colon Cancer: The Potential Value of Prognostic Molecular Markers." Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology vol. 30,9 (2021): 1726-1734. doi: https://doi.org/10.1158/1055-9965.EPI-21-0078
Jongeneel G, Greuter MJE, Kunst N, van Erning FN, Koopman M, Medema JP, Vermeulen L, Ijzermans JNM, Vink GR, Punt CJA, Coupé VMH. Early Cost-effectiveness Analysis of Risk-Based Selection Strategies for Adjuvant Treatment in Stage II Colon Cancer: The Potential Value of Prognostic Molecular Markers. Cancer Epidemiol Biomarkers Prev. 2021 Sep;30(9):1726-1734. doi: 10.1158/1055-9965.EPI-21-0078. Epub 2021 Jun 23. PMID: 34162659; PMCID: PMC7611620.
Copy Download .nbib Format: NLM
Impact of geography on prognostic outcomes of 21,509 patients with metastatic colorectal cancer enrolled in clinical trials: an ARCAD database analysis.

Therapeutic advances in medical oncology

Yin J, Dawood S, Cohen R, Meyers J, Zalcberg J, Yoshino T, Seymour M, Maughan T, Saltz L, Van Cutsem E, Venook A, Schmoll HJ, Goldberg R, Hoff P, Hecht JR, Hurwitz H, Punt C, Diaz Rubio E, Koopman M, Cremolini C, Heinemann V, Tournigard C, Bokemeyer C, Fuchs C, Tebbutt N, Souglakos J, Doulliard JY, Kabbinavar F, Chibaudel B, de Gramont A, Shi Q, Grothey A, Adams R.
PMID: 34262614
Ther Adv Med Oncol. 2021 Jun 30;13:17588359211020547. doi: 10.1177/17588359211020547. eCollection 2021.

BACKGROUND: Benchmarking international cancer survival differences is necessary to evaluate and improve healthcare systems. Our aim was to assess the potential regional differences in outcomes among patients with metastatic colorectal cancer (mCRC) participating in international randomized clinical trials (RCTs).DESIGN:...

Cite
Yin J, Dawood S, Cohen R, et al. Impact of geography on prognostic outcomes of 21,509 patients with metastatic colorectal cancer enrolled in clinical trials: an ARCAD database analysis. Ther Adv Med Oncol. 2021;13:17588359211020547doi: 10.1177/17588359211020547.
Yin, J., Dawood, S., Cohen, R., Meyers, J., Zalcberg, J., Yoshino, T., Seymour, M., Maughan, T., Saltz, L., Van Cutsem, E., Venook, A., Schmoll, H. J., Goldberg, R., Hoff, P., Hecht, J. R., Hurwitz, H., Punt, C., Diaz Rubio, E., Koopman, M., Cremolini, C., Heinemann, V., Tournigard, C., Bokemeyer, C., Fuchs, C., Tebbutt, N., Souglakos, J., Doulliard, J. Y., Kabbinavar, F., Chibaudel, B., de Gramont, A., Shi, Q., Grothey, A., & Adams, R. (2021). Impact of geography on prognostic outcomes of 21,509 patients with metastatic colorectal cancer enrolled in clinical trials: an ARCAD database analysis. Therapeutic advances in medical oncology, 1317588359211020547. https://doi.org/10.1177/17588359211020547
Yin, Jun, et al. "Impact of geography on prognostic outcomes of 21,509 patients with metastatic colorectal cancer enrolled in clinical trials: an ARCAD database analysis." Therapeutic advances in medical oncology vol. 13 (2021): 17588359211020547. doi: https://doi.org/10.1177/17588359211020547
Yin J, Dawood S, Cohen R, Meyers J, Zalcberg J, Yoshino T, Seymour M, Maughan T, Saltz L, Van Cutsem E, Venook A, Schmoll HJ, Goldberg R, Hoff P, Hecht JR, Hurwitz H, Punt C, Diaz Rubio E, Koopman M, Cremolini C, Heinemann V, Tournigard C, Bokemeyer C, Fuchs C, Tebbutt N, Souglakos J, Doulliard JY, Kabbinavar F, Chibaudel B, de Gramont A, Shi Q, Grothey A, Adams R. Impact of geography on prognostic outcomes of 21,509 patients with metastatic colorectal cancer enrolled in clinical trials: an ARCAD database analysis. Ther Adv Med Oncol. 2021 Jun 30;13:17588359211020547. doi: 10.1177/17588359211020547. eCollection 2021. PMID: 34262614; PMCID: PMC8252342.
Copy Download .nbib Format: NLM
The Prospective Dutch Colorectal Cancer (PLCRC) cohort: real-world data facilitating research and clinical care.

Scientific reports

Derksen JWG, Vink GR, Elferink MAG, Roodhart JML, Verkooijen HM, van Grevenstein WMU, Siersema PD, May AM, Koopman M.
PMID: 33594104
Sci Rep. 2021 Feb 16;11(1):3923. doi: 10.1038/s41598-020-79890-y.

Real-world data (RWD) sources are important to advance clinical oncology research and evaluate treatments in daily practice. Since 2013, the Prospective Dutch Colorectal Cancer (PLCRC) cohort, linked to the Netherlands Cancer Registry, serves as an infrastructure for scientific research...

Cite
Derksen JWG, Vink GR, Elferink MAG, et al. The Prospective Dutch Colorectal Cancer (PLCRC) cohort: real-world data facilitating research and clinical care. Sci Rep. 2021;11(1):3923doi: 10.1038/s41598-020-79890-y.
Derksen, J. W. G., Vink, G. R., Elferink, M. A. G., Roodhart, J. M. L., Verkooijen, H. M., van Grevenstein, W. M. U., Siersema, P. D., May, A. M., Koopman, M. (2021). The Prospective Dutch Colorectal Cancer (PLCRC) cohort: real-world data facilitating research and clinical care. Scientific reports, 11(1), 3923. https://doi.org/10.1038/s41598-020-79890-y
Derksen, Jeroen W G, et al. "The Prospective Dutch Colorectal Cancer (PLCRC) cohort: real-world data facilitating research and clinical care." Scientific reports vol. 11,1 (2021): 3923. doi: https://doi.org/10.1038/s41598-020-79890-y
Derksen JWG, Vink GR, Elferink MAG, Roodhart JML, Verkooijen HM, van Grevenstein WMU, Siersema PD, May AM, Koopman M. The Prospective Dutch Colorectal Cancer (PLCRC) cohort: real-world data facilitating research and clinical care. Sci Rep. 2021 Feb 16;11(1):3923. doi: 10.1038/s41598-020-79890-y. PMID: 33594104; PMCID: PMC7887218.
Copy Download .nbib Format: NLM
A pilot study on the feasibility and effectiveness of treadmill-based perturbations for assessing and improving walking stability in chronic obstructive pulmonary disease.

Clinical biomechanics (Bristol, Avon)

McCrum C, Vaes AW, Delbressine JM, Koopman M, Liu WY, Willems P, Meijer K, Spruit MA.
PMID: 34823220
Clin Biomech (Bristol, Avon). 2021 Nov 21;91:105538. doi: 10.1016/j.clinbiomech.2021.105538. Epub 2021 Nov 21.

BACKGROUND: Falls risk is elevated in chronic obstructive pulmonary disease (COPD). However, there is a lack of evidence regarding the contributing factors. Here, we examined the feasibility of, and initial responses to, large walking perturbations in COPD, as well...

Cite
McCrum C, Vaes AW, Delbressine JM, et al. A pilot study on the feasibility and effectiveness of treadmill-based perturbations for assessing and improving walking stability in chronic obstructive pulmonary disease. Clin Biomech (Bristol, Avon). 2021;91:105538doi: 10.1016/j.clinbiomech.2021.105538.
McCrum, C., Vaes, A. W., Delbressine, J. M., Koopman, M., Liu, W. Y., Willems, P., Meijer, K., & Spruit, M. A. (2021). A pilot study on the feasibility and effectiveness of treadmill-based perturbations for assessing and improving walking stability in chronic obstructive pulmonary disease. Clinical biomechanics (Bristol, Avon), 91105538. https://doi.org/10.1016/j.clinbiomech.2021.105538
McCrum, Christopher, et al. "A pilot study on the feasibility and effectiveness of treadmill-based perturbations for assessing and improving walking stability in chronic obstructive pulmonary disease." Clinical biomechanics (Bristol, Avon) vol. 91 (2021): 105538. doi: https://doi.org/10.1016/j.clinbiomech.2021.105538
McCrum C, Vaes AW, Delbressine JM, Koopman M, Liu WY, Willems P, Meijer K, Spruit MA. A pilot study on the feasibility and effectiveness of treadmill-based perturbations for assessing and improving walking stability in chronic obstructive pulmonary disease. Clin Biomech (Bristol, Avon). 2021 Nov 21;91:105538. doi: 10.1016/j.clinbiomech.2021.105538. Epub 2021 Nov 21. PMID: 34823220.
Copy Download .nbib Format: NLM
A pilot study on the feasibility and effectiveness of treadmill-based perturbations for assessing and improving walking stability in chronic obstructive pulmonary disease.

Clinical biomechanics (Bristol, Avon)

McCrum C, Vaes AW, Delbressine JM, Koopman M, Liu WY, Willems P, Meijer K, Spruit MA.
PMID: 34823220
Clin Biomech (Bristol, Avon). 2021 Nov 21;91:105538. doi: 10.1016/j.clinbiomech.2021.105538. Epub 2021 Nov 21.

BACKGROUND: Falls risk is elevated in chronic obstructive pulmonary disease (COPD). However, there is a lack of evidence regarding the contributing factors. Here, we examined the feasibility of, and initial responses to, large walking perturbations in COPD, as well...

Cite
McCrum C, Vaes AW, Delbressine JM, et al. A pilot study on the feasibility and effectiveness of treadmill-based perturbations for assessing and improving walking stability in chronic obstructive pulmonary disease. Clin Biomech (Bristol, Avon). 2021;91:105538doi: 10.1016/j.clinbiomech.2021.105538.
McCrum, C., Vaes, A. W., Delbressine, J. M., Koopman, M., Liu, W. Y., Willems, P., Meijer, K., & Spruit, M. A. (2021). A pilot study on the feasibility and effectiveness of treadmill-based perturbations for assessing and improving walking stability in chronic obstructive pulmonary disease. Clinical biomechanics (Bristol, Avon), 91105538. https://doi.org/10.1016/j.clinbiomech.2021.105538
McCrum, Christopher, et al. "A pilot study on the feasibility and effectiveness of treadmill-based perturbations for assessing and improving walking stability in chronic obstructive pulmonary disease." Clinical biomechanics (Bristol, Avon) vol. 91 (2021): 105538. doi: https://doi.org/10.1016/j.clinbiomech.2021.105538
McCrum C, Vaes AW, Delbressine JM, Koopman M, Liu WY, Willems P, Meijer K, Spruit MA. A pilot study on the feasibility and effectiveness of treadmill-based perturbations for assessing and improving walking stability in chronic obstructive pulmonary disease. Clin Biomech (Bristol, Avon). 2021 Nov 21;91:105538. doi: 10.1016/j.clinbiomech.2021.105538. Epub 2021 Nov 21. PMID: 34823220.
Copy Download .nbib Format: NLM
Interculturality and cultural intelligence in an academic context: A report from university staff interacting with nursing students.

Journal of education and health promotion

Shomoossi N, Asor AA, Kooshan M, Rad M.
PMID: 31143795
J Educ Health Promot. 2019 Apr 24;8:78. doi: 10.4103/jehp.jehp_120_18. eCollection 2019.

INTRODUCTION: The cultural diversity of ethnic groups in Iranian academic contexts highlights the importance of enhancing cultural awareness and minimizing cultural conflicts. Therefore, the present study aimed to investigate the intercultural intelligence of the university personnel in interacting with...

Cite
Shomoossi N, Asor AA, Kooshan M, et al. Interculturality and cultural intelligence in an academic context: A report from university staff interacting with nursing students. J Educ Health Promot. 2019;8:78doi: 10.4103/jehp.jehp_120_18.
Shomoossi, N., Asor, A. A., Kooshan, M., & Rad, M. (2019). Interculturality and cultural intelligence in an academic context: A report from university staff interacting with nursing students. Journal of education and health promotion, 878. https://doi.org/10.4103/jehp.jehp_120_18
Shomoossi, Nematullah, et al. "Interculturality and cultural intelligence in an academic context: A report from university staff interacting with nursing students." Journal of education and health promotion vol. 8 (2019): 78. doi: https://doi.org/10.4103/jehp.jehp_120_18
Shomoossi N, Asor AA, Kooshan M, Rad M. Interculturality and cultural intelligence in an academic context: A report from university staff interacting with nursing students. J Educ Health Promot. 2019 Apr 24;8:78. doi: 10.4103/jehp.jehp_120_18. eCollection 2019. PMID: 31143795; PMCID: PMC6512398.
Copy Download .nbib Format: NLM
Factors Contributing to Cancer-Related Muscle Wasting During First-Line Systemic Treatment for Metastatic Colorectal Cancer.

JNCI cancer spectrum

Derksen JWG, Kurk SA, Oskam MJ, Peeters PHM, Punt CJA, Koopman M, May AM.
PMID: 31360897
JNCI Cancer Spectr. 2019 Apr 25;3(2):pkz014. doi: 10.1093/jncics/pkz016. eCollection 2019 Jun.

BACKGROUND: Increasing evidence indicates that loss of muscle mass is associated with adverse outcomes in metastatic colorectal cancer. Here, we investigate which demographic, lifestyle- (smoking), tumor-, and treatment-related factors are associated with muscle loss in patients with metastatic colorectal...

Cite
Derksen JWG, Kurk SA, Oskam MJ, et al. Factors Contributing to Cancer-Related Muscle Wasting During First-Line Systemic Treatment for Metastatic Colorectal Cancer. JNCI Cancer Spectr. 2019;3(2):pkz014doi: 10.1093/jncics/pkz016.
Derksen, J. W. G., Kurk, S. A., Oskam, M. J., Peeters, P. H. M., Punt, C. J. A., Koopman, M., & May, A. M. (2019). Factors Contributing to Cancer-Related Muscle Wasting During First-Line Systemic Treatment for Metastatic Colorectal Cancer. JNCI cancer spectrum, 3(2), pkz014. https://doi.org/10.1093/jncics/pkz016
Derksen, Jeroen W G, et al. "Factors Contributing to Cancer-Related Muscle Wasting During First-Line Systemic Treatment for Metastatic Colorectal Cancer." JNCI cancer spectrum vol. 3,2 (2019): pkz014. doi: https://doi.org/10.1093/jncics/pkz016
Derksen JWG, Kurk SA, Oskam MJ, Peeters PHM, Punt CJA, Koopman M, May AM. Factors Contributing to Cancer-Related Muscle Wasting During First-Line Systemic Treatment for Metastatic Colorectal Cancer. JNCI Cancer Spectr. 2019 Apr 25;3(2):pkz014. doi: 10.1093/jncics/pkz016. eCollection 2019 Jun. PMID: 31360897; PMCID: PMC6649832.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 76 entries